Takeshi Wakashima

The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease

S. Hasegawa, Tetsuhiro Tanaka, Tomoyuki Saito et al. · Kidney International · 2019 · 125 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice

Mai Sugahara, Tetsuhiro Tanaka, Hisako Saito et al. · Journal of the American Society of Nephrology · 2020 · 105 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Prolyl hydroxylase inhibition protects the kidneys from ischemia via upregulation of glycogen storage

Marie Ito, Tetsuhiro Tanaka, Taisuke Ishii et al. · Kidney International · 2019 · 90 citations

Life Sciences, Biochemistry, Pharmacology +14

Lorenzo's oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid

Takayuki Sassa, Takeshi Wakashima, Yusuke Ohno et al. · Journal of Lipid Research · 2014 · 67 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Cooperative Synthesis of Ultra Long-Chain Fatty Acid and Ceramide during Keratinocyte Differentiation

Yukiko Mizutani, Hui Sun, Yusuke Ohno et al. · PLoS ONE · 2013 · 49 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17